Effects of age and aerobic fitness on myocardial lipid content

Circulation: Cardiovascular Imaging

Volumn 6, Issue 6, 2013, Pages 1048-1055

  Sarma, Satyam ^a,b   Carrick Ranson, Graeme ^a,b   Fujimoto, Naoki ^a,b   Adams Huet, Beverley ^b   Bhella, Paul S ^a,b   Hastings, Jeffrey L ^a,b   Shafer, Keri M ^a,b   Shibata, Shigeki ^a,b   Boyd, Kara ^a   Palmer, Dean ^a   Szczepaniak, Edward W ^c   Szczepaniak, Lidia S ^c   Levine, Benjamin D ^a,b  

^a Institute for Exercise and Environmental Medicine Dallas   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Aging; Exercise; Ventricular remodeling

Indexed keywords

LIPID;

ADULT; AEROBIC EXERCISE; AGE; AGED; ARTICLE; BODY COMPOSITION; BODY MASS; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXERCISE TEST; FATTY ACID METABOLISM; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE FILLING PRESSURE; HEART MUSCLE; HEART PRELOAD; HUMAN; HUMAN EXPERIMENT; LIPID STORAGE; MALE; MYOCARDIAL LIPID CONTENT; NORMAL HUMAN; OXYGEN CONSUMPTION; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; SEDENTARY LIFESTYLE; TREADMILL EXERCISE; VERY ELDERLY;

AGING; EXERCISE; VENTRICULAR REMODELING;

ADULT; AGED; AGED, 80 AND OVER; AGING; EXERCISE; EXERCISE TEST; FEMALE; HUMANS; LIPIDS; MAGNETIC RESONANCE IMAGING, CINE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MYOCARDIUM; REFERENCE VALUES; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84892157628     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.113.000565     Document Type: Article

References (31)

1. Fujimoto N, Hastings JL, Bhella P.S., Shibata S., Gandhi NK, Carrick-Ranson G, Palmer D, Levine BD Effect of ageing on left ventricular compliance and distensibility in healthy sedentary humans. J Physiol. 2012; 590(pt 8):1871-1880.
2. Carrick-Ranson G., Hastings JL, Bhella P.S., Shibata S., Fujimoto N, Palmer MD, Boyd K, Levine BD Effect of healthy aging on left ventricular relaxation and diastolic suction. Am J Physiol Heart Circ Physiol. 2012; 303:H315-H322.
3. Dorfman TA, Rosen BD, Perhonen M.A., Tillery T., McColl R, Peshock RM, Levine BD Diastolic suction is impaired by bed rest: MRI tagging studies of diastolic untwisting. J Appl Physiol. 2008; 104:1037-1044.
4. Perhonen MA, Franco F, Lane L.D., Buckey JC, Blomqvist CG, Zerwekh JE, Peshock R.M., Weatherall PT, Levine BD Cardiac atrophy after bed rest and spaceflight. J Appl Physiol. 2001; 91:645-653.
5. Arbab-Zadeh A., Dijk E, Prasad A., Fu Q, Torres P, Zhang R., Thomas JD, Palmer D, Levine BD Effect of aging and physical activity on left ventricular compliance. Circulation. 2004; 110:1799-1805.
6. Naylor LH, Arnolda LF, Deague J.A., Playford D., Maurogiovanni A, O'Driscoll G, Green DJ Reduced ventricular flow propagation velocity in elite athletes is augmented with the resumption of exercise training. J Physiol. 2005; 563(pt 3):957-963.
7. Evans WJ, Cyr-Campbell D. Nutrition, exercise, and healthy aging. J Am Diet Assoc. 1997; 97:632-638.
8. Unger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology. 2003; 144:5159-5165.
9. Park TS, Hu Y, Noh H.L., Drosatos K., Okajima K, Buchanan J, Tuinei J., Homma S, Jiang XC, Abel E.D., Goldberg IJ Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. J Lipid Res. 2008; 49:2101-2112.
10. Zhou YT, Grayburn P, Karim A., Shimabukuro M, Higa M, Baetens D., Orci L, Unger RH Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A. 2000; 97:1784-1789.
11. Finck BN, Lehman JJ, Leone T.C., Welch MJ, Bennett MJ, Kovacs A, Han X., Gross RW, Kozak R, Lopaschuk GD, Kelly DP The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest. 2002; 109:121-130.
12. Vikramadithyan RK, Hirata K, Yagyu H., Hu Y, Augustus A, Homma S., Goldberg IJ Peroxisome proliferator-activated receptor agonists modulate heart function in transgenic mice with lipotoxic cardiomyopathy. J Pharmacol Exp Ther. 2005; 313:586-593.
13. Son NH, Park TS, Yamashita H, Yokoyama M., Huggins LA, Okajima K, Homma S, Szabolcs M.J., Huang LS, Goldberg IJ Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice. J Clin Invest. 2007; 117:2791-2801.
14. Korosoglou G, Humpert PM, Ahrens J, Oikonomou D., Osman NF, Gitsioudis G, Buss SJ, Steen H, Schnackenburg B., Bierhaus A, Nawroth PP, Katus HA Left ventricular diastolic function in type 2 diabetes mellitus is associated with myocardial triglyceride content but not with impaired myocardial perfusion reserve. J Magn Reson Imaging. 2012; 35:804-811.
15. Ng AC, Delgado V, Bertini M., van der Meer RW, Rijzewijk LJ, Hooi Ewe S, Siebelink HM, Smit JW, Diamant M, Romijn JA, de Roos A, Leung DY, Lamb HJ, Bax JJ. Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus. Circulation. 2010; 122:2538-2544.
16. Rijzewijk LJ, van der Meer RW, Smit JW, Diamant M, Bax JJ, Hammer S, Romijn JA, de Roos A, Lamb HJ. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol. 2008; 52:1793-1799.
17. Szczepaniak LS, Dobbins RL, Metzger G.J., Sartoni-D'Ambrosia G, Arbique D, Vongpatanasin W, Unger R, Victor RG. Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med. 2003; 49:417-423.
18. Marfella R, Di Filippo C, Portoghese M, Barbieri M., Ferraraccio F, Siniscalchi M, Cacciapuoti F., Rossi F, D'Amico M, Paolisso G. Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome. J Lipid Res. 2009; 50:2314-2323.
19. Victor RG, Haley RW, Willett D.L., Peshock RM, Vaeth PC, Leonard D, Basit M., Cooper RS, Iannacchione VG, Visscher WA, Staab J.M., Hobbs HH; Dallas Heart Study Investigators. The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol. 2004; 93:1473-1480.
20. Lorenzo S, Babb TG Quantification of cardiorespiratory fitness in healthy nonobese and obese men and women. Chest. 2012; 141:1031-1039.
21. Katz J, Milliken MC, Stray-Gundersen J, Buja L.M., Parkey RW, Mitchell JH, Peshock RM Estimation of human myocardial mass with MR imaging. Radiology. 1988; 169:495-498.
22. McGavock JM, Lingvay I, Zib I., Tillery T, Salas N, Unger R., Levine BD, Raskin P, Victor RG, Szczepaniak LS Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation. 2007; 116:1170-1175.
23. Jarvis SS, Levine BD, Prisk G.K., Shykoff BE, Elliott AR, Rosow E, Blomqvist C.G., Pawelczyk JA Simultaneous determination of the accuracy and precision of closed-circuit cardiac output rebreathing techniques. J Appl Physiol. 2007; 103:867-874.
24. Mirsky I. Assessment of diastolic function: suggested methods and future considerations. Circulation. 1984; 69:836-841.
25. Kenchaiah S, Evans JC, Levy D, Wilson P.W., Benjamin EJ, Larson MG, Kannel WB, Vasan RS Obesity and the risk of heart failure. N Engl J Med. 2002; 347:305-313.
26. Nichols GA, Gullion CM, Koro C.E., Ephross SA, Brown JB The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care. 2004; 27:1879-1884.
27. Taegtmeyer H, McNulty P, Young ME Adaptation and maladaptation of the heart in diabetes: part I: general concepts. Circulation. 2002; 105:1727-1733.
28. Gaborit B, Kober F, Jacquier A., Moro PJ, Cuisset T, Boullu S, Dadoun F., Alessi MC, Morange P, Clément K, Bernard M., Dutour A. Assessment of epicardial fat Volume and myocardial triglyceride content in severely obese subjects: relationship to metabolic profile, cardiac function and visceral fat. Int J Obes (Lond). 2012; 36:422-430.
29. Hunter GR, Chandler-Laney PC, Brock D.W., Lara-Castro C, Fernandez JR, Gower BA Fat distribution, aerobic fitness, blood lipids, and insulin sensitivity in African-American and European-American women. Obesity (Silver Spring). 2010; 18:274-281.
30. van de Weijer T, Schrauwen-Hinderling VB, Schrauwen P. Lipotoxicity in type 2 diabetic cardiomyopathy. Cardiovasc Res. 2011; 92:10-18.
31. Clark AL, Fonarow GC, Horwich TB Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited. J Card Fail. 2011; 17:374-380.